We are live on ! Find out more
ASB

AdvanSource Biomaterials Corp

Delisted

ASB was delisted on the 23rd of November, 2010.

1 hedge funds and large institutions have $12 invested in AdvanSource Biomaterials Corp in 2014 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
BRWA
B. Riley Wealth Advisors
Florida
+$12

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
BRWA
1
B. Riley Wealth Advisors
Florida
$12 +$12 +61,500 New

ASB Hedge Fund Activity: Q4 2014 in Review

1 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in AdvanSource Biomaterials Corp (ASB) for Q4 2014, worth a combined $12.

Buyers outnumbered sellers: 1 fund opened new ASB positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was B. Riley Wealth Advisors, opening a new position worth an estimated $12.

  • 1 institutional investor held AdvanSource Biomaterials Corp (ASB) as of Q4 2014, up from 0 in Q3 2014.
  • Funds reported $12 of AdvanSource Biomaterials Corp stock for Q4 2014.
  • 1 fund opened new AdvanSource Biomaterials Corp positions in Q4 2014 and 0 closed out, a net change of +1 holder.
  • The largest AdvanSource Biomaterials Corp buyer in Q4 2014 was B. Riley Wealth Advisors, an estimated $12 added.

Based on aggregated 13F filings for Q4 2014.